Dopa-responsive dystonia--clinical and genetic heterogeneity
Subhashie Wijemanne1, Joseph Jankovic1
1Parkinson's Disease Centre and Movement Disorders Clinic, Baylor College of Medicine, McNair Campus, 7200 Cambridge Street, Suite 9A, Houston, TX 77030, USA.
Nature Reviews. Neurology
|June 24, 2015
Summary
Dopa-responsive dystonia (DRD) is a group of disorders causing fluctuating dystonia, often misdiagnosed. Early diagnosis via specific tests ensures timely levodopa treatment for better outcomes.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Dopa-responsive dystonia (DRD) presents as limb-onset, diurnal dystonia responsive to levodopa.
- It is genetically heterogeneous, with GTP cyclohydrolase 1 deficiency (Segawa disease) being the most common cause.
- Rarer causes include conditions not affecting dopamine biosynthesis, such as hereditary spastic paraplegia type 11.
Purpose of the Study:
- To review common and rare causes of DRD.
- To detail clinical features associated with DRD.
- To outline optimal diagnostic approaches for early detection and treatment.
Main Methods:
- Literature review of conditions causing DRD.
- Analysis of clinical presentations and genetic underpinnings.
- Evaluation of diagnostic strategies including levodopa trials and genetic testing.
Main Results:
- DRD encompasses diverse genetic and clinical presentations.
- Misdiagnosis is common due to heterogeneity, delaying levodopa treatment.
- A range of diagnostic tests are available, tailored to clinical complexity.
Conclusions:
- Early and accurate diagnosis of DRD is crucial for effective management.
- A systematic diagnostic approach is necessary to identify the underlying cause.
- Timely intervention with levodopa improves patient outcomes significantly.
Related Concept Videos
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Drugs Affecting Neurotransmitter Synthesis
2.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.6K
Genetic Lingo
118.4K
Overview
118.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Human Genetics
1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K


